June 22, 2020 / 11:35 AM / 15 days ago

BRIEF-Resverlogix Reaches Agreement With FDA For Key Aspects Of Apabetalone Registration Enabling Study

Resverlogix Corp:

* RESVERLOGIX REACHES AGREEMENT WITH FDA FOR KEY ASPECTS OF APABETALONE REGISTRATION ENABLING STUDY

* RESVERLOGIX - NDA WITH FDA IS POSSIBLE AFTER UNEQUIVOCAL EFFICACY AT INTERIM ANALYSIS OF BETONMACE2 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below